Digital Health Interventions for Depression and Anxiety in Low- and Middle-Income Countries: Rapid Scoping Review
- PMID: 40846319
- PMCID: PMC12413575
- DOI: 10.2196/68296
Digital Health Interventions for Depression and Anxiety in Low- and Middle-Income Countries: Rapid Scoping Review
Abstract
Background: Low- and middle-income countries (LMICs), which bear a larger proportion of the global mental illness burden, have been disproportionately impacted by the COVID-19 pandemic due to preexisting mental health care system deficiencies. The pandemic has also led to a considerable increase in care delivered through digital mental health interventions (DMHIs), many of which have been adapted from in-person formats. Thus, there is a need to examine their fidelity to the original format along with issues regarding usability and other challenges to and facilitators of their uptake in LMICs. As most DMHIs have been developed in high-income countries, examining their cultural adaptation to LMIC settings is also critical.
Objective: The purpose of this research was to conduct a rapid scoping review of the available evidence on DMHIs for depression and anxiety, two of the most common mental disorders, in LMICs.
Methods: A rapid scoping review was conducted following the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) and processes for rapid reviews by Tricco et al. The PubMed and PsycINFO databases were searched for records published between January 2020 (when COVID-19 was declared a public health emergency) and January 2025 using a search strategy developed in consultation with a liaison librarian. The pandemic accelerated the development and application of DMHIs, and this time frame was used to capture the recent literature that may have incorporated new methods of application. The search strategy was developed across three domains: (1) digital health interventions, (2) depression or anxiety, and (3) LMICs. Data were charted from the final records according to (1) intervention type; (2) discussions on fidelity, usability, and cultural adaptation; and (3) challenges to and facilitators of their uptake in LMICs.
Results: A total of 80 records were included in the final analysis, with reasons for exclusion (eg, focused on mental health in general, not being a DMHI, or not focused on LMICs) reported. Six DMHI platforms were identified: (1) mobile app, (2) the web, (3) virtual reality, (4) videoconferencing, (5) telemedicine, and (6) social media. Less than half of the records referenced fidelity (16/80, 20%), usability (29/80, 36%), and cultural adaptation (31/80, 39%). Challenges pertained to the technological system, engagement issues, structural barriers, and concerns regarding privacy and confidentiality. Facilitators included widespread mobile phone use, built-in supervision and training features, and convenience.
Conclusions: Despite the opportunities that DMHIs offer for reducing the mental health treatment gap, further work examining and improving their fidelity, usability, and cultural adaptation is required. In addition, various challenges to the uptake of DMHIs in LMICs, including contextual issues, structural barriers, and privacy concerns, must be mitigated to avoid contributing further to the digital divide.
Keywords: COVID-19; LMICs; anxiety; cultural adaptation; depression; digital health; fidelity; implementation science; low- and middle-income countries; mHealth; mental health; mobile health; usability.
©Leena W Chau, Raymond W Lam, Harry Minas, Kanna Hayashi, Vu Cong Nguyen, John O'Neil. Originally published in JMIR Mental Health (https://mental.jmir.org), 22.08.2025.
Conflict of interest statement
Conflicts of Interest: RWL has received honoraria for ad hoc speaking, advising, or consulting or received research funds from AbbVie, the Asia-Pacific Economic Cooperation, Bausch, the British Columbia Leading Edge Foundation, Brain Canada, the Canadian Institutes of Health Research, the Canadian Medical Protective Association, the Canadian Network for Mood and Anxiety Treatments, Carnot, CB Solutions, Genome British Columbia, Grand Challenges Canada, Healthy Minds Canada, Janssen, Lundbeck, the Michael Smith Foundation for Health Research, Mitacs, Neurotorium, the Ontario Brain Institute, Otsuka, the Shanghai Mental Health Center, Unity Health, the Vancouver Coastal Health Research Institute, and the Vancouver General Hospital and University of British Columbia Hospital Foundation. All other authors declare no conflicts of interest.
Figures
Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Digital Mental Health Interventions for Adolescents in Low- and Middle-Income Countries: Scoping Review.J Med Internet Res. 2024 Oct 29;26:e51376. doi: 10.2196/51376. J Med Internet Res. 2024. PMID: 39471371 Free PMC article.
-
Challenges and Mitigation Strategies in the Development and Feasibility Assessment of a Digital Mental Health Intervention for Depression (VMood): Mixed Methods Feasibility Study.JMIR Form Res. 2025 Jun 30;9:e68297. doi: 10.2196/68297. JMIR Form Res. 2025. PMID: 40587849 Free PMC article.
-
Providing Human Support for the Use of Digital Mental Health Interventions: Systematic Meta-review.J Med Internet Res. 2023 Feb 6;25:e42864. doi: 10.2196/42864. J Med Internet Res. 2023. PMID: 36745497 Free PMC article.
-
Needs and Expectations for the myNewWay Blended Digital and Face-to-Face Psychotherapy Model of Care for Depression and Anxiety (Part 1): Participatory Design Study including People with Lived and Living Experience.JMIR Hum Factors. 2025 Jun 11;12:e69499. doi: 10.2196/69499. JMIR Hum Factors. 2025. PMID: 40499157 Free PMC article.
References
-
- GBD 2019 Mental Disorders Collaborators Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022 Feb;9(2):137–50. doi: 10.1016/S2215-0366(21)00395-3.S2215-0366(21)00395-3 - DOI - PMC - PubMed
-
- Torous J, Jän Myrick K, Rauseo-Ricupero N, Firth J. Digital mental health and COVID-19: using technology today to accelerate the curve on access and quality tomorrow. JMIR Ment Health. 2020 Mar 26;7(3):e18848. doi: 10.2196/18848. https://mental.jmir.org/2020/3/e18848/ v7i3e18848 - DOI - PMC - PubMed
-
- Zheng J, Morstead T, Sin N, Klaiber P, Umberson D, Kamble S, DeLongis A. Psychological distress in North America during COVID-19: the role of pandemic-related stressors. Soc Sci Med. 2021 Feb;270:113687. doi: 10.1016/j.socscimed.2021.113687. https://europepmc.org/abstract/MED/33465600 S0277-9536(21)00019-8 - DOI - PMC - PubMed
-
- COVID-19 Mental Disorders Collaborators Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021 Nov 06;398(10312):1700–12. doi: 10.1016/S0140-6736(21)02143-7. https://linkinghub.elsevier.com/retrieve/pii/S0140-6736(21)02143-7 S0140-6736(21)02143-7 - DOI - PMC - PubMed
-
- Patel V, Saxena S, Lund C, Thornicroft G, Baingana F, Bolton P, Chisholm D, Collins PY, Cooper JL, Eaton J, Herrman H, Herzallah MM, Huang Y, Jordans MJ, Kleinman A, Medina-Mora ME, Morgan E, Niaz U, Omigbodun O, Prince M, Rahman A, Saraceno B, Sarkar BK, De Silva M, Singh I, Stein DJ, Sunkel C, UnÜtzer J. The Lancet Commission on global mental health and sustainable development. Lancet. 2018 Oct 27;392(10157):1553–98. doi: 10.1016/S0140-6736(18)31612-X.S0140-6736(18)31612-X - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous